ProShare Advisors LLC has reported a 13.9% increase in its holdings in Shockwave Medical, Inc. (SWAV:NSD) as per the recent filing with the Securities and Exchange Commission. The company purchased an additional 895 shares of Shockwave Medical stock during the 4th quarter, bringing its total holdings to 7,355 SWAV stock shares worth $1,512,000.
Other institutional investors that increased their stake in the company include Fifth Third Bancorp, Profund Advisors, Signaturefd LLC, Fulton Bank N.A., and Lincoln National Corp.
Shockwave Medical Stock Price Analysis:
Shockwave Medical stock opened at $281.01 on Wednesday, and it has a one-year low of $113.36 and a one-year high of $320.54. The company’s market cap is $10.28 billion, and it has a P/E ratio of 49.30 and a beta of 0.98.
Analysts predict that Shockwave Medical will post 3.92 earnings per share for the current year, and the company has a consensus rating of “Strong Buy” with an average price target of $261.91.
Company Profile:
ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.
It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
